Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more
Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Total Assets
Latest total assets as of September 2025: NT$1.99 Billion TWD
Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) holds total assets worth NT$1.99 Billion TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Johnson Chemical Pharmaceutical Works Co Ltd - Total Assets Trend (2009–2024)
This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Johnson Chemical Pharmaceutical Works Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Johnson Chemical Pharmaceutical Works Co Ltd's total assets of NT$1.99 Billion consist of 68.0% current assets and 32.0% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 54.5% |
| Accounts Receivable | NT$101.05 Million | 5.1% |
| Inventory | NT$140.90 Million | 7.2% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2009–2024)
This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Johnson Chemical Pharmaceutical Works Co Ltd's current assets represent 68.0% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 54.5% of total assets in 2024, up from 21.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 7.2% of total assets.
Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Total Assets
Key competitors of Johnson Chemical Pharmaceutical Works Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Johnson Chemical Pharmaceutical Works Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Johnson Chemical Pharmaceutical Works Co Ltd generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Johnson Chemical Pharmaceutical Works Co Ltd generates $ 4.28 in net profit.
Johnson Chemical Pharmaceutical Works Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.76 | 7.65 | 2.27 |
| Quick Ratio | 4.15 | 6.84 | 1.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.05 Billion | NT$ 1.14 Billion | NT$ 304.68 Million |
Johnson Chemical Pharmaceutical Works Co Ltd - Advanced Valuation Insights
This section examines the relationship between Johnson Chemical Pharmaceutical Works Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.49 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | NT$1.97 Billion |
| Market Capitalization | $43.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Johnson Chemical Pharmaceutical Works Co Ltd's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Johnson Chemical Pharmaceutical Works Co Ltd's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)
The table below shows the annual total assets of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.97 Billion | -1.39% |
| 2023-12-31 | NT$1.99 Billion | +91.77% |
| 2022-12-31 | NT$1.04 Billion | +1.18% |
| 2021-12-31 | NT$1.03 Billion | -6.50% |
| 2020-12-31 | NT$1.10 Billion | +15.42% |
| 2019-12-31 | NT$951.76 Million | +1.59% |
| 2018-12-31 | NT$936.82 Million | +0.62% |
| 2017-12-31 | NT$931.07 Million | -2.56% |
| 2016-12-31 | NT$955.50 Million | +4.13% |
| 2015-12-31 | NT$917.57 Million | +22.02% |
| 2014-12-31 | NT$752.00 Million | +10.01% |
| 2013-12-31 | NT$683.60 Million | +50.49% |
| 2012-12-31 | NT$454.24 Million | +2.84% |
| 2011-12-31 | NT$441.70 Million | +11.40% |
| 2010-12-31 | NT$396.51 Million | +7.55% |
| 2009-12-31 | NT$368.69 Million | -- |